Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

BACKGROUND: Intraperitoneal chemotherapy using paclitaxel is considered an experimental approach for treating peritoneal carcinomatosis. This study aimed to determine the recommended dose, and to evaluate the clinical efficacy and safety, of the combination of intravenous gemcitabine, intravenous na...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Surg
Main Authors: Yamada, S., Fujii, T., Yamamoto, T., Takami, H., Yoshioka, I., Yamaki, S., Sonohara, F., Shibuya, K., Motoi, F., Hirano, S., Murakami, Y., Inoue, H., Hayashi, M., Murotani, K., Kitayama, J., Ishikawa, H., Kodera, Y., Sekimoto, M., Satoi, S.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd. 2020
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689756/
https://ncbi.nlm.nih.gov/pubmed/32638367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.11792
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki